These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 16010539)

  • 1. The differential effects of ecstasy/polydrug use on executive components: shifting, inhibition, updating and access to semantic memory.
    Montgomery C; Fisk JE; Newcombe R; Murphy PN
    Psychopharmacology (Berl); 2005 Oct; 182(2):262-76. PubMed ID: 16010539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for selective executive function deficits in ecstasy/polydrug users.
    Fisk JE; Montgomery C
    J Psychopharmacol; 2009 Jan; 23(1):40-50. PubMed ID: 18515461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Everyday and prospective memory deficits in ecstasy/polydrug users.
    Hadjiefthyvoulou F; Fisk JE; Montgomery C; Bridges N
    J Psychopharmacol; 2011 Apr; 25(4):453-64. PubMed ID: 20123936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ecstasy-related deficits in the updating component of executive processes.
    Montgomery C; Fisk JE
    Hum Psychopharmacol; 2008 Aug; 23(6):495-511. PubMed ID: 18512857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
    de Sola Llopis S; Miguelez-Pan M; Peña-Casanova J; Poudevida S; Farré M; Pacifici R; Böhm P; Abanades S; Verdejo García A; Langohr K; Zuccaro P; de la Torre R
    J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-reports of executive dysfunction in current ecstasy/polydrug Users.
    Hadjiefthyvoulou F; Fisk JE; Montgomery C; Bridges N
    Cogn Behav Neurol; 2012 Sep; 25(3):128-38. PubMed ID: 22960437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the functional significance of ecstasy-related memory deficits using a virtual paradigm.
    Montgomery C; Hatton NP; Fisk JE; Ogden RS; Jansari A
    Hum Psychopharmacol; 2010; 25(4):318-25. PubMed ID: 20521322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. fNIRS suggests increased effort during executive access in ecstasy polydrug users.
    Roberts CA; Montgomery C
    Psychopharmacology (Berl); 2015 May; 232(9):1571-82. PubMed ID: 25391436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for executive deficits among users of MDMA (Ecstasy).
    Fisk JE; Montgomery C; Murphy P; Wareing M
    Br J Psychol; 2004 Nov; 95(Pt 4):457-66. PubMed ID: 15527532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of executive functioning in ecstasy/polydrug users.
    Roberts CA; Jones A; Montgomery C
    Psychol Med; 2016 Jun; 46(8):1581-96. PubMed ID: 26966023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective memory functioning among ecstasy/polydrug users: evidence from the Cambridge Prospective Memory Test (CAMPROMPT).
    Hadjiefthyvoulou F; Fisk JE; Montgomery C; Bridges N
    Psychopharmacology (Berl); 2011 Jun; 215(4):761-74. PubMed ID: 21301817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired executive function in male MDMA ("ecstasy") users.
    von Geusau NA; Stalenhoef P; Huizinga M; Snel J; Ridderinkhof KR
    Psychopharmacology (Berl); 2004 Sep; 175(3):331-41. PubMed ID: 15034712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users.
    Fox HC; McLean A; Turner JJ; Parrott AC; Rogers R; Sahakian BJ
    Psychopharmacology (Berl); 2002 Jul; 162(2):203-14. PubMed ID: 12110998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiological evidence of atypical processing underlying mental set shifting in ecstasy polydrug and polydrug users.
    Roberts CA; Fairclough SH; McGlone FP; Fisk JE; Montgomery C
    Exp Clin Psychopharmacol; 2013 Dec; 21(6):507-15. PubMed ID: 24080019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Updating of working memory in ecstasy polydrug users: Findings from fNIRS.
    Montgomery C; Fisk JE; Roberts CA
    Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28631348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Everyday memory deficits in ecstasy-polydrug users.
    Montgomery C; Fisk JE
    J Psychopharmacol; 2007 Sep; 21(7):709-17. PubMed ID: 17606476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic ecstasy (MDMA) use is associated with deficits in task-switching but not inhibition or memory updating executive functions.
    Dafters RI
    Drug Alcohol Depend; 2006 Jun; 83(2):181-4. PubMed ID: 16316723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective memory deficits in illicit polydrug users are associated with the average long-term typical dose of ecstasy typically consumed in a single session.
    Gallagher DT; Hadjiefthyvoulou F; Fisk JE; Montgomery C; Robinson SJ; Judge J
    Neuropsychology; 2014 Jan; 28(1):43-54. PubMed ID: 24015828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Information processing speed in ecstasy (MDMA) users.
    Wareing M; Fisk JE; Montgomery C; Murphy PN; Chandler MD
    Hum Psychopharmacol; 2007 Mar; 22(2):81-8. PubMed ID: 17295197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes.
    Reay JL; Hamilton C; Kennedy DO; Scholey AB
    J Psychopharmacol; 2006 May; 20(3):385-8. PubMed ID: 16574712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.